Nordic Nanovector ASA announced that Jostein Dahle, chief scientific officer and co-founder, leaves the company. Together with Roy Hartvig Larsen and Ãyvind Sverre Bruland, Jostein Dahle established Nordic Nanovector in 2009.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.038 NOK | -3.17% | -1.70% | -19.53% |
28/02 | Transcript : Thor Medical ASA, H2 2023 Earnings Call, Feb 28, 2024 | |
14/02 | Thor Medical ASA Announces CEO Changes | CI |
1st Jan change | Capi. | |
---|---|---|
-19.53% | 22.48M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- TRMED Stock
- News Thor Medical
- Nordic Nanovector ASA Announces Resignation of Jostein Dahle, Chief Scientific Officer and Co-Founder